4.4 Article

Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults

Journal

OPEN FORUM INFECTIOUS DISEASES
Volume 9, Issue 3, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofac027

Keywords

COVID-19; longitudinal cohort; SARS-CoV-2; viral evolution; viral load

Funding

  1. Office of the Provost
  2. Office for Research
  3. Northwestern University Information Technology
  4. Northwestern Medicine Enterprise Data Warehouse
  5. Northwestern University Clinical and Translational Science Institute (NUCATS, NIH) [UL1 TR001422]
  6. Northwestern Institute for Global Health Catalyzer Research Fund award
  7. NUCATS COVID-19 Collaborative Innovation Award
  8. Dixon Translational Research Grant of the Dixon Family Foundation
  9. CTSA supplement to NCATS [UL1 TR002389]
  10. Northwestern University Cancer Center [P30 CA060553]
  11. Center for Structural Genomics of Infectious Diseases at Northwestern University (NIH/NIAID) [HHSN272201700060C]
  12. Gilead Sciences Research Scholars Program in HIV
  13. NIH-supported Third Coast Center for AIDS Research [P30 AI117943]
  14. National Institutes of Health [U19 AI135964, 3UL1 TR001422-06S4]
  15. Walder Foundation

Ask authors/readers for more resources

This study found that the outcome of COVID-19 is associated with factors such as gender, age, body mass index, 4C Mortality score, and lactate dehydrogenase levels. Only the retrospectively calculated median Deterioration Index score was significantly associated with death. Furthermore, viral load was not significantly associated with outcome, suggesting that immune dysfunction plays a more crucial role in disease severity.
Background While several demographic and clinical correlates of coronavirus disease 2019 (COVID-19) outcome have been identified, their relationship to virological and immunological parameters remains poorly defined. Methods To address this, we performed longitudinal collection of nasopharyngeal swabs and blood samples from a cohort of 58 hospitalized adults with COVID-19. Samples were assessed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load, viral genotype, viral diversity, and antibody titer. Demographic and clinical information, including patient blood tests and several composite measures of disease severity, was extracted from electronic health records. Results Several factors, including male sex, higher age, higher body mass index, higher 4C Mortality score, and elevated lactate dehydrogenase levels, were associated with intensive care unit admission. Of all measured parameters, only the retrospectively calculated median Deterioration Index score was significantly associated with death. While quantitative polymerase chain reaction cycle threshold (Ct) values and genotype of SARS-CoV-2 were not significantly associated with outcome, Ct value did correlate positively with C-reactive protein levels and negatively with D-dimer, lymphocyte count, and antibody titer. Intrahost viral genetic diversity remained constant through the disease course and resulted in changes in viral genotype in some participants. Conclusions Ultimately, these results suggest that worse outcomes are driven by immune dysfunction rather than by viral load and that SARS-CoV-2 evolution in hospital settings is relatively constant over time.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available